Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 - Wikidata - awgldk - TriplyDB

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

http://www.wikidata.org/entity/Q24609814

about

Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3.Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release An early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain core HIV type 1 Gag as a target for antiviral therapy Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)An assembly domain of the Rous sarcoma virus Gag protein required late in budding Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin Differential membrane binding of the human immunodeficiency virus type 1 matrix protein Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1 New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells Single-Cell and Single-Cycle Analysis of HIV-1 Replication Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production Lipids and membrane microdomains in HIV-1 replication Structure of equine infectious anemia virus matrix protein.Point Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl Switch Entropic switch regulates myristate exposure in the HIV-1 matrix protein Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters Joint X-ray/Neutron Crystallographic Study of HIV-1 Protease with Clinical Inhibitor Amprenavir: Insights for Drug Design Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.The aspartic proteases Non-viral cellular substrates for human immunodeficiency virus type 1 protease Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid

P2860

Q24290922-A940F019-2781-41AF-BE22-815ED12817BB Q24292892-6302A326-BDD3-4612-A1FB-781C60532D56 Q24530002-857A629B-538A-49AE-BB5B-88F130B32D70 Q24531508-43C6BEED-5C63-4C0A-8A74-CED27C96D240 Q24559906-3D776ABE-8E5E-463B-A5ED-8D51AC540E9D Q24561846-8F78C534-33C4-4A21-946E-9EC110CF4146 Q24563651-1E82E1E2-2DB3-4DA8-99E1-B540F1AC5A43 Q24567661-3855AD21-786F-456E-9231-6AD2B6B3B6CC Q24614498-5444397D-86CE-4239-89C6-8E5CBEC0FD99 Q24633537-8CA660C3-B653-4DD3-AD2E-ABA6E0DD74EE Q24645654-B56A98C9-2D04-4779-8A63-DE509A0B8CC8 Q24646680-39C13873-3192-4928-A795-F65F15330D82 Q24647043-6725DF7F-855F-41DB-9101-A2B298BEF988 Q24673913-92E69ED1-6144-4AD5-87C4-9C9E012FD830 Q24676673-7C236CA0-C9CB-4032-917C-083AA8C3F672 Q24679629-C648EC00-CA8B-4177-985E-5E7269683701 Q24681117-8A1AE9CE-33F9-4A2A-9367-07C3ABC55AD8 Q24681172-AC14FED8-9DD5-4717-9F01-5E14A7509400 Q24799654-01CFFD62-2B70-44C2-8456-C37D05F95AD8 Q26739673-329F3006-5708-4012-A5DA-95E22134E232 Q26851321-DA6AA7D1-4640-4FB9-8F28-E6179B1A86DC Q27312753-FEA4F530-A3C8-431D-80AD-6EE424F55BD0 Q27319151-E494B4D9-01ED-4791-9B8C-5CFDE3423359 Q27485930-77F53236-944B-45A4-89E3-C6D6BD506348 Q27489393-AFF96EE3-1A75-4C05-82EB-16AB24AA5DE7 Q27637386-7F12D384-3766-450F-9925-C20CB484EBF6 Q27640933-C1D1F9E4-310B-40FD-993D-6595401ADFDF Q27642873-E6FCAC91-E6FA-47AF-83D8-8CCE1663D992 Q27663981-0960B614-BCD8-4CB0-A177-0161E0C4E123 Q27678644-CEFEFE98-A6A4-45AD-BA1D-36A6EA1B6500 Q27732646-20B0E349-421F-4B99-8C21-CEDDE113AB64 Q27939857-5A3B5EED-83E7-4F36-9D09-4DCD9C0E9B47 Q28208915-E4215976-7AD9-4E20-9D57-66E671A9E9EC Q28264830-6EB22E27-E7CE-4682-865D-4158A3E45F74 Q28272788-F6591372-E0FD-4316-92A3-11F5A0BAE9D0 Q28318483-F5D9F25C-AF3A-441D-B466-1A0033FCC807 Q28325705-E8E002AB-87C5-4D0F-AB44-5CE2C67642E7 Q28331494-8F5E8B13-B71C-422C-9AB3-42925C925E1B Q28335088-D3C81A94-B3FE-476A-88DE-8D7ACBCCCB86 Q28359721-B1CEF14C-FE32-4D7E-A455-29363112ED16

P2860

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

http://www.wikidata.org/entity/Q24609814

description

1989 nî lūn-bûn

@nan

1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Role of capsid precursor proce ...... immunodeficiency virus type 1

@ast

Role of capsid precursor proce ...... immunodeficiency virus type 1

@en

Role of capsid precursor proce ...... immunodeficiency virus type 1

@nl

type

label

Role of capsid precursor proce ...... immunodeficiency virus type 1

@ast

Role of capsid precursor proce ...... immunodeficiency virus type 1

@en

Role of capsid precursor proce ...... immunodeficiency virus type 1

@nl

prefLabel

Role of capsid precursor proce ...... immunodeficiency virus type 1

@ast

Role of capsid precursor proce ...... immunodeficiency virus type 1

@en

Role of capsid precursor proce ...... immunodeficiency virus type 1

@nl

P1433

Q24609814-5BED97D6-1317-45BC-9C2A-F17279A0052F

P1476

Q24609814-98B57147-2664-48E3-8A2B-5A6D9E739A8D

P2093

Q24609814-90C3B801-2B06-4E2C-9E68-E85ECF013D58

Q24609814-C3A97B08-F993-4490-8AC1-7A878EBCC1B7

P2860

Q24609814-0121CDCD-5B85-4B92-869C-FD827CC910D8

Q24609814-061B8359-D479-455E-81EE-9BA102955688

Q24609814-0F66C408-A94D-4832-91C6-B19F30AA12BD

Q24609814-2AA2FE00-847D-4EAB-9116-586F1D0B23FC

Q24609814-2B8CE237-204C-4AE5-BE25-2A6BCFD136A1

Q24609814-3638E46A-F72A-4A58-8DE6-87BCB5AF9DD4

Q24609814-3ADFCD95-5072-4A10-97D2-81FD83F17F54

Q24609814-3E93290C-7126-4333-972B-C8F12A342FBD

Q24609814-45078717-391C-4A7F-8A23-6EADE12B926E

Q24609814-50CFD007-BB64-4FA7-9372-A1EEB58A071C

P304

Q24609814-4829B24F-3B7A-4731-8263-680CBE1AF59D

P31

Q24609814-B8C9C3F1-9FCE-4301-BE3A-A3EAF708463D

P3181

Q24609814-F59D934F-F492-4866-8DEA-FDB6AA058840

P356

Q24609814-E1F9CC4C-8800-4EA7-A2EB-1169D32D70B4

P407

Q24609814-F28C6217-9945-4F1C-8018-5EACC99FFF8B

P433

Q24609814-F08E3323-A206-4107-B747-ACA39221BA4C

P478

Q24609814-8C448117-F3E2-4FE9-8086-731178B7AD73

P50

Q24609814-FBE523AC-88D1-4ACA-AA3A-1E0385756E71

P577

Q24609814-8DD6799B-53AE-4226-8651-939CC7491A49

P5875

Q24609814-C5CFC339-0E04-404D-9338-110EC84B0205

P698

Q24609814-315C8AA0-0D00-498E-8B4A-14038EB5BEB4

P921

Q24609814-09BBD8EC-4FAF-4F3D-8935-76CEF47580B8

Q24609814-3FFABA91-49B7-4870-9071-699A3C10B94C

P932

Q24609814-FCAF519C-49D3-465B-B6AA-FEBAAE957F65

P3181

P356

PNAS.86.15.5781

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Role of capsid precursor proce ...... immunodeficiency virus type 1

@en

P2093

H G Göttlinger

http://www.w3.org/2001/XMLSchema#string

J G Sodroski

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Active human immunodeficiency virus protease is required for viral infectivity

Rapid and efficient site-specific mutagenesis without phenotypic selection

Complete nucleotide sequence of the AIDS virus, HTLV-III

Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

Use of eukaryotic expression technology in the functional analysis of cloned genes

A structural model for the retroviral proteases.

Functional role of human immunodeficiency virus type 1 vpu.

Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.

P304

5781-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

914493

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.86.15.5781

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

William A. Haseltine

P577

1989-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20368522

http://www.w3.org/2001/XMLSchema#string

P698

2788277

http://www.w3.org/2001/XMLSchema#string

P921

P932

297714

http://www.w3.org/2001/XMLSchema#string